PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
August 24, 2021Pharmacological Research835 citationsOpen Access

The role of microbiota-gut-brain axis in neuropsychiatric and neurological disorders

View Full Paper
KSKatarzyna SocałaUDUrszula DoboszewskaASAleksandra Szopa

Key Points

  • Synthesize preclinical and clinical evidence on how the microbiota-gut-brain axis contributes to the pathogenesis and progression of neuropsychiatric and neurological disorders.
  • Reviewed findings from in vivo preclinical experiments, including germ-free animal models and animal models of central nervous system disease.
  • Evaluated clinical profiling studies characterizing gut microbiota composition in human neurological and psychiatric conditions.
  • Examined interventional trials and preclinical studies using probiotics, prebiotics, antibiotics, and fecal microbiota transplantation.
  • Gut microbes modulate neurotransmission, neural development, and behavior across conditions including depression, anxiety, schizophrenia, autism spectrum disorders, Parkinson's disease, migraine, and epilepsy.
  • Microbial alterations frequently co-exist with gastrointestinal dysfunction in patients with neuropsychiatric and neurodevelopmental conditions.
  • Modulating gut community composition through dietary interventions, probiotics, prebiotics, or fecal microbiota transplantation alters neurobehavioral outcomes in experimental models.

Abstract

Emerging evidence indicates that the gut microbiota play a crucial role in the bidirectional communication between the gut and the brain suggesting that the gut microbes may shape neural development, modulate neurotransmission and affect behavior, and thereby contribute to the pathogenesis and/or progression of many neurodevelopmental, neuropsychiatric, and neurological conditions. This review summarizes recent data on the role of microbiota-gut-brain axis in the pathophysiology of neuropsychiatric and neurological disorders including depression, anxiety, schizophrenia, autism spectrum disorders, Parkinson's disease, migraine, and epilepsy. Also, the involvement of microbiota in gut disorders co-existing with neuropsychiatric conditions is highlighted. We discuss data from both in vivo preclinical experiments and clinical reports including: (1) studies in germ-free animals, (2) studies exploring the gut microbiota composition in animal models of diseases or in humans, (3) studies evaluating the effects of probiotic, prebiotic or antibiotic treatment as well as (4) the effects of fecal microbiota transplantation.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Socała et al. (2021) studied this question.

synapsesocial.com/papers/69d723adef370a38abf50e1fhttps://doi.org/10.1016/j.phrs.2021.105840
Ask AI
Helpful
Bookmark
Share
View Full Paper